华润双鹤药业股份有限公司2025年半年度报告摘要

Core Viewpoint - The company plans to distribute a cash dividend of 1.00 yuan per 10 shares for the first half of 2025, which represents 10.65% of the net profit attributable to shareholders [2][53]. Group 1: Profit Distribution Plan - The total number of shares after the cancellation of restricted stocks is 1,038,757,509, leading to a total cash dividend distribution of approximately 103.88 million yuan (including tax) [2][53]. - The remaining undistributed profits amount to approximately 5.90 billion yuan for the parent company and 9.73 billion yuan for the consolidated entity, which will be carried forward for future distribution [2]. - The profit distribution plan is subject to approval by the shareholders' meeting [3][55]. Group 2: Company Bond Issuance - The company plans to issue bonds with a total scale not exceeding 30 billion yuan, with specific issuance amounts to be determined based on market conditions and funding needs [17][60]. - The bonds will have a face value of 100 yuan each and will be issued at par [61]. - The funds raised will be used for repaying interest-bearing debts, supporting investments and acquisitions, and supplementing working capital [67][77]. Group 3: Company Overview and Financial Data - The company has a total share capital of 1,038,836,522 shares as of June 30, 2025 [2]. - The company’s financial condition is stable, with a good credit rating over the past three years [71]. - The company has been focusing on enhancing operational quality and increasing investment returns through various initiatives [78].